The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit

Anesthesia and Analgesia

Volumn 101, Issue 1, 2005, Pages 220-225

  Pandey, Chandra Kant ^a   Raza, Mehdi ^a   Tripathi, Mukesh ^a   Navkar, Deepa V ^a   Kumar, Abhishek ^a   Singh, Uttam K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FENTANYL; GABAPENTIN; PETHIDINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; EVALUATION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INTENSIVE CARE UNIT; MALE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SEDATION;

ADULT; AMINES; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CARBAMAZEPINE; CONSCIOUS SEDATION; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; GAMMA-AMINOBUTYRIC ACID; GUILLAIN-BARRE SYNDROME; HUMANS; INTENSIVE CARE; MALE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 20744443148     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000152186.89020.36     Document Type: Article

References (28)

1. Moulin DE, Hagen N, Feasby TE, et al. Pain in Guillain-Barré syndrome. Neurology 1997;48:328-1.
2. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha (2) delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000;131:282-6.
3. Tripathi M, Kaushik S. Carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Crit Care Med 2000;28:655-8.
4. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;28: 1831-6.
5. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
6. Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998;51:609-11.
7. McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology 1997;86:988-90.
8. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 1997;48: 1467.
9. Pandey CK, Bose N, Garg G, et al. Gabapentin for the treatment of pain in Guillain-Barré Syndrome: a double blinded, placebo-controlled, crossover study. Anesth Analg 2002;95:1719-23.
10. Pandey CK, Priye S, Singh S, et al. Preemptive use of gabapentin significantly decreases postoperative pain and supplementary analgesic requirements in laparoscopic cholecystectomy. Can J Anaesth 2004;51:358-63.
11. Werner MU, Perkins FM, Holte K, et al. Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med 2001;26:322-8.
12. Dirks J, Fredensborg BB, Christensen D, et al. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology 2002;97:560-4.
13. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002;95:985-91.
14. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2: 656-9.
15. Henschel EO. The Guillain-Barré syndrome: a personal experience. Anesthesiology 1977;47:228-31.
16. Connelly M, Shagrin J, Warfield C. Epidural opioids for the management of pain in a patient with the Guillain-Barré syndrome. Anesthesiology 1990;72:381-3.
17. Genis D, Busquets C, Manubens E, et al. Epidural morphine analgesia in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1989;52:999-1001.
18. Albright PS. Effect of carbamazepine, clonazepam and phenytoin on seizure threshold in amygdala and cortex. Exp Neurol 1983;79:11-7.
19. Macdonald RL. Anticonvulsant drug actions on neurons in cell culture. J Neural Transm 1988;72:173-83.
20. Feng Y, Cui M, Willis WD. Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003;98: 729-33.
21. Tracey DJ, De Biasi S, Phend K, Rustioni A. Aspartate-like immunoreactivity in primary afferent neurons. Neuroscience 1991;40:673-86.
22. Kapetanovic IM, Yonekawa WD, Kupferberg HJ. The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro. Epilepsy Res 1995;20:113-20.
23. Patel S, Naeem S, Kesingland A, et al. The effect of GABA (B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 2001;90: 217-26.
24. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha (2) delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000;131:282-6.
25. Flink K, Meder W, Dooley DJ, Gothart M. Inhibition of neuronal Ca (2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical sites. Br J Pharmacol 2000;130:900-6.
26. Hutson SM, Berkich D, Drown P, et al. Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J Neurochem 1998;71:863-74.
27. Stoelting RK. Pharmacology and physiology in anesthetic practice. 3rd ed. Philadelphia: Lippincott-Raven, 1999.
28. McLean MJ, Morrel MJ, Willmore LJ, et al. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia 1999;40:965-72.